Abstract
During the past years, cardiac resynchronization therapy (CRT) has become a recognized treatment option for patients with heart failure and conduction delays. In the meantime, the principle of re-synchronizing a dyssynchronous ventricle can be regarded as established.1 The challenge of correctly identifying the patient candidates who will benefit from this costly and not completely non-invasive therapy, however, remains.

This publication has 8 references indexed in Scilit: